SEC Form 4 · accession 0001193125-26-262205
Tango Therapeutics, Inc. · TNGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lesley Ann Calhoun
Director
Period of report
Jun 5, 2026
Accepted (ET)
Jun 8, 2026 · 6:01 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001819133
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 5, 2026 | A | 4,000 | $0.00 | A | 16,500 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $20.22 | Jun 5, 2026 | A | 25,000 | A | — | Jun 5, 2036 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in their entirety on the earlier of: (i) June 5, 2027 and (ii) the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.
- F2This option shall vest and become exercisable in 12 substantially equal monthly installments over a period of one year, with the first vesting date on July 5, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.
Remarks
Exhibit 24: Power of Attorney